CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure The association between body mass index and obesity with survival in pulmonary arterial hypertension Prospective Elimination of Distal Coronary Sinus to Left Atrial Connection for Atrial Fibrillation Ablation (PRECAF) Randomized Controlled Trial Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome

Review ArticleVolume 13, Issue 16, August 2020

JOURNAL:JACC: Cardiovascular Interventions Article Link

Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When

TJ Ford, P Ong, and on behalf of the COVADIS Study Group Keywords: angina; ischemic heart disease; microvascular angina; MINOCA; stratified medicine; vasospastic angina

Full Text PDF